We report the occurrence of chronic kidney disease after living-related kidney transplant involving monozygotic twin brothers of Afro-Caribbean origin who were both heterozygous for the G1 and G2 APOL1 kidney disease risk alleles. A 21 year-old black man with endstage kidney disease of unknown aetiology received a kidney from his monozygotic twin brother (confirmed by microsatellite analysis). Thirty months after transplantation, the patient presented proteinuria and decreased eGFR with typical focal segmental glomerulosclerosis lesions on the graft biopsy. He received steroid therapy, but progressed to kidney failure 5 years later. The twin brother displayed normal kidney function without proteinuria at the time of transplant; however, 7 years later, he exhibited decreased estimated GFR (40 ml/min/1.73m) and proteinuria (2.5 g/day). APOL1 genotyping of revealed that both donor and recipient were heterozygous for the G1 and G2 alleles. This unique case is in stark contrast to expectations for identical twin transplantation and suggests a role for APOL1 polymorphisms in both the donor and recipient.
Introduction
The risk of non-diabetic chronic kidney disease (CKD) is 4-5 times higher for people of African ancestry than other groups 1, 2 . This was recently attributed to two sequence variants, G1 and G2, in the last exon of the APOL1 gene, encoding apolipoprotein L-1: these variants are common in African Americans but absent from people of European ancestry 3 . People with two risk alleles have an increased risk of focal and segmental glomerulosclerosis (FSGS), hypertension-related end-stage renal disease (ESRD), and HIV-associated nephropathy [3] [4] [5] . The ethnic origin of kidney transplantation recipients may influence the graft function outcome, and recipients with African ancestry are usually considered as at high risk of poor kidney outcome, although a French survey does not support this view [6] [7] [8] [9] . The relationship between APOL1 risk variant alleles and allograft survival after kidney transplantation has been evaluated in two recent studies 10, 11 . The first study, with 2 years of post-transplant follow-up, showed that graft survival was significantly shorter in transplant recipients of donor kidneys with two APOL1 risk variant alleles 11 . By contrast, a retrospective study did not find that the 5-year post-transplant graft survival correlated with the APOL1 genotype of the recipient 10 . Further investigations are required to clarify the consequences of both recipient and donor APOL1 genotype on the graft outcome after kidney transplantation.
We describe here, for the first time, FSGS of the graft after a living-related kidney transplant and unsatisfactory kidney function outcome in the donor for a pair of monozygous twin brothers sharing the same APOL1 risk variant genotype.
Case report
A Seven years after donation, the donor displayed significant proteinuria (2.53 g/day) without haematuria but associated with decreased eGFR (creatinine 2.5 mg/dL; and eGFR: 40 ml/min/1.73m²) (Figure 2 ). We did not perform a kidney biopsy on the remaining kidney.
The synchronous apparition of kidney disease may point toward a hereditary FSGS. As
Lipska et al recently suggested 13 , we performed the sequencing of the integrality of podocin gene and did not identify any mutation. In the light of recent reports of genetic susceptibility associated with FSGS in people of African ancestry, we genotyped the APOL1 gene in both donor and recipient and both were heterozygous for the G1 and G2 APOL1 risk alleles ( Figure 3 ).
Discussion
We report here the first case of a decreased eGFR in both donor and recipient after living-related kidney transplantation involving twin brothers with APOL1 polymorphisms.
This critical issue contrasts with the excellent expected outcome in a living donation between two monozygotic twins. A recent study clearly indicates that kidney allograft survival is shorter in patients receiving deceased donor kidneys from African Americans with two APOL1 risk alleles than those receiving other kidneys 11 . Based on these findings, it was suggested that APOL1 status should be used for potential live kidney donors. However, this the pathological process leading to the kidney disease remains to be determined. Possibly, the variable clinical and histological patterns of kidney disease are related to a "two hits" event:
firstly a donor related genetic variant and a second hit, which may be viral, metabolic or environmental 16 . It is plausible that nephronic reduction and hyperfiltration related to kidney donation constituted such a second hit in our case.
Our observation is also unusual in that the donor and recipient are monozygotic twin brothers. This is a particularly suitable context for analysing the APOL1-related phenotype/genotype relationship. At the time of donation, the recipient exhibited ESRD with significant proteinuria and hypertension and the donor's kidney function and blood pressure were considered to be normal. The recipient exhibited an early recurrence of FSGS and donor displayed decreased eGFR with mild proteinuria five years post-transplant donation. These different outcomes illustrate the well-known concept of phenotypic discordance between monozygotic twins which might be related to environmental differences but also to epigenetic modifications of histones and DNA 17 such as DNA methylation profiles 18 .
Finally, we describe the first case of chronic kidney disease in both monozygotic twins carrying APOL1 polymorphism after kidney donation that is known to be a risk factor to graft loss. The mechanisms involved in kidney disease after donation required further experimental and human genetic studies. The twins express both at-risk alleles: G1 (consisting of variants derived from rs73885319 and rs60910145) that encodes a protein with two nonsynonymous amino acid substitutions, and G2 (rs71785313) that encodes a protein with a deletion of two amino acids from the same C terminal domain of APOL1.
Arrows indicate the position of the mutations.
